These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27293058)

  • 61. Relationship between circulating and tissue microRNAs in a murine model of breast cancer.
    Waters PS; McDermott AM; Wall D; Heneghan HM; Miller N; Newell J; Kerin MJ; Dwyer RM
    PLoS One; 2012; 7(11):e50459. PubMed ID: 23226290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isolation of secreted microRNAs (miRNAs) from cell-conditioned media.
    Glynn CL; Khan S; Kerin MJ; Dwyer RM
    Microrna; 2013; 2(1):14-9. PubMed ID: 25070711
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
    Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
    Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Histological features of tumor-bearing tissues formed by human fibroblasts after reprograming by Piwil2].
    Zeng G; Wu X; He D; Fu Y; Liu X; Zhang D; Lin T; Wei G
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):565-72. PubMed ID: 26714595
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.
    Toraih EA; Mohammed EA; Farrag S; Ramsis N; Hosny S
    Mol Diagn Ther; 2015 Jun; 19(3):179-90. PubMed ID: 26063582
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of
    Savari B; Boozarpour S; Tahmasebi-Birgani M; Sabouri H; Hosseini SM
    Microrna; 2020; 9(1):58-63. PubMed ID: 30887933
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
    Orlandella FM; Mariniello RM; Mirabelli P; De Stefano AE; Iervolino PLC; Lasorsa VA; Capasso M; Giannatiempo R; Rongo M; Incoronato M; Messina F; Salvatore M; Soricelli A; Salvatore G
    Br J Cancer; 2020 Aug; 123(3):426-437. PubMed ID: 32418991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues.
    Damavandi Z; Torkashvand S; Vasei M; Soltani BM; Tavallaei M; Mowla SJ
    J Breast Cancer; 2016 Jun; 19(2):148-55. PubMed ID: 27382390
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclin D1 promotes secretion of pro-oncogenic immuno-miRNAs and piRNAs.
    Lü J; Zhao Q; Ding X; Guo Y; Li Y; Xu Z; Li S; Wang Z; Shen L; Chen HW; Yu Z; Pestell RG
    Clin Sci (Lond); 2020 Apr; 134(7):791-805. PubMed ID: 32219337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of breast cancer and bone metastasis by microRNAs.
    Vimalraj S; Miranda PJ; Ramyakrishna B; Selvamurugan N
    Dis Markers; 2013; 35(5):369-87. PubMed ID: 24191129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Search of MicroRNAs Regulating the Receptor Status of Breast Cancer In Silico and Experimental Confirmation of Their Expression in Tumors.
    Chernyi VS; Tarasova PV; Kozlov VV; Saik OV; Kushlinskii NE; Gulyaeva LF
    Bull Exp Biol Med; 2017 Sep; 163(5):655-659. PubMed ID: 28944429
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNAs as biomarkers for breast cancer.
    Canatan D; Sönmez Y; Yılmaz Ö; Çim A; Coşkun HŞ; Sezgin Göksu S; Ucar S; Aktekin MR
    Acta Biomed; 2021 May; 92(2):e2021028. PubMed ID: 33988168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells.
    Rady M; Watzl C; Claus M; Khorshid O; Mahran L; Abou-Aisha K
    Sci Rep; 2017 Feb; 7():41381. PubMed ID: 28145491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.
    Nejati K; Alivand M; Arabzadeh A
    Pathol Res Pract; 2021 Jul; 223():153452. PubMed ID: 33993061
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.
    Chen PS; Su JL; Cha ST; Tarn WY; Wang MY; Hsu HC; Lin MT; Chu CY; Hua KT; Chen CN; Kuo TC; Chang KJ; Hsiao M; Chang YW; Chen JS; Yang PC; Kuo ML
    J Clin Invest; 2011 Sep; 121(9):3442-55. PubMed ID: 21841313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers.
    Laddha SV; Nayak S; Paul D; Reddy R; Sharma C; Jha P; Hariharan M; Agrawal A; Chowdhury S; Sarkar C; Mukhopadhyay A
    Biol Direct; 2013 Apr; 8():10. PubMed ID: 23618224
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Loss of microRNA-200a expression correlates with tumor progression in breast cancer.
    Jang K; Ahn H; Sim J; Han H; Abdul R; Paik SS; Chung MS; Jang SJ
    Transl Res; 2014 Mar; 163(3):242-51. PubMed ID: 24280074
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
    Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA-21 in breast cancer: diagnostic and prognostic potential.
    Chen J; Wang X
    Clin Transl Oncol; 2014 Mar; 16(3):225-33. PubMed ID: 24248894
    [TBL] [Abstract][Full Text] [Related]  

  • 80. miR-107 and miR-126 and Risk of Breast Cancer: A Case-Control Study.
    Gupta P; Sambyal V; Bali JS; Guleria K; Uppal MS; Sudan M
    Genet Test Mol Biomarkers; 2024 Apr; 28(4):165-168. PubMed ID: 38487920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.